Oesophageal Atresia: Prevalence in the Valencian Region (Spain) and Associated Anomalies

Adriana Agurto-Ramírez1, Laura García-Villodre2, Ana Ruiz-Palacio2

  • 1Service of Preventive Medicine, Valencia General University Hospital Consortium, 46014 Valencia, Spain.

Insights

Oesophageal atresia (OA) affects 2.4/10,000 births in the Valencian Region. Most cases occur in live births, often with other congenital anomalies, and mortality is linked to birth weight.

Area of Science:

  • Pediatric Surgery
  • Medical Genetics
  • Public Health

Background:

  • Oesophageal atresia (OA) is a congenital anomaly requiring early diagnosis and intervention.
  • Understanding the prevalence and characteristics of OA is crucial for public health planning and resource allocation.
  • Previous studies highlight variations in OA incidence and associated factors.

Purpose of the Study:

  • To determine the prevalence of oesophageal atresia (OA) in the Valencian Region (VR) between 2007 and 2019.
  • To describe the epidemiological and clinical characteristics of OA cases.
  • To analyze mortality rates and associated factors in OA patients.

Main Methods:

  • Population-based registry study using data from the Congenital Anomalies Registry of VR (RPAC-CV).
  • Inclusion of live births (LB), stillbirths (SB), and terminations of pregnancy for fetal anomaly (TOPFA) diagnosed with OA.
  • Calculation of prevalence rates (per 10,000 births) and analysis of socio-demographic and clinical variables.

Main Results:

  • A total of 146 OA cases were identified, with an overall prevalence of 2.4/10,000 births.
  • Prevalence was higher in live births (2.3/10,000) compared to stillbirths and TOPFA (0.03/10,000).
  • Mortality rate was 0.03/1000 LB, with a significant association between mortality and birth weight. 71.2% of cases had associated anomalies, primarily heart defects.

Conclusions:

  • The prevalence of OA in the VR is within the expected range, with lower rates in SB and TOPFA compared to EUROCAT data.
  • An association between OA and birth weight, as well as other congenital anomalies, was confirmed.
  • Significant variations in OA prevalence were observed during the study period, warranting further investigation.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
110
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
230
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
129
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
111
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
145
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
213